Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum


Rafati, S; Nakhaee, A; Taheri, T; Taslimi, Y; Darabi, F; Eravani, D; Sanos, S; Kaye, P; Taghikhani, M; Jamshidi, S; Rad, MA; (2005) Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum. Vaccine, 23 (28). pp. 3716-3725. ISSN 0264-410X DOI: 10.1016/j.vaccine.2005.02.009

Full text not available from this repository.

Abstract

Leishmania infantum is known to be associated with visceral leishmaniasis in Iran and canids are natural reservoirs. Control of disease in dogs appears to be one of the most effective approaches for interrupting the domestic cycle of the disease. In search for successful vaccine strategies, we evaluated the cysteine proteinases (Cps) type I and II using a heterologous prime-boost regime for vaccination against experimental visceral leishmaniasis in dogs, Following vaccination and challenge, dogs were followed for 12 months, Ten dogs vaccinated by prime/boost with DNA/recombinant CPs (in combination with CpG ODN and Montanide 720) remained free of infection in their bone morrow. In contrast, three out of four dogs in the control groups had infection in their bone marrow. The peripheral lymphocytes from protected animals had generally higher proliferation responses to F/T antigen. recombinant CPA (rCPA) and recombinant CPB (rCPB) than controls. During post-challenge period, the difference in stimulation index is significant (p < 0,05) on months 11 and 12 to F/T antigens. all months for rCPA and 5, 7 9, 11 and 12 months for rCPB, Analysis of cytokine mRNA level suggested that vaccinated dogs had elevated IFN-gamma mRNA in peripheral blood mononuclear cells (PBMC). whereas there was a consistent increase in the level of IL-10 in the control groups and some vaccinated dogs. The level of total IgG and IgG2, but not IgG 1, to rCPA and rCPB was significantly higher in the vaccinated group (p < 0,05) than the control groups. We also showed that with the exception of one dog. all dogs in the vaccinated group in comparison to control dogs had strong DTH responses. We propose that the combination of DNA and recombinant protein vaccination using CPs could he instrumental to control (VL) in dogs. (c) 2005 Elsevier Ltd. All rights reserved.

Item Type: Article
Keywords: dog DNA vaccination, canine visceral leishmaniasis, cysteine, proteinases type I and II, CpG ODN, CUTANEOUS LEISHMANIASIS, IMMUNE-RESPONSES, KALA-AZAR, BALB/C MICE, DOGS, INFECTION, PROMASTIGOTES, DIAGNOSIS, VACCINES, Animals, Antibodies, Protozoan, blood, Antigens, Protozoan, administration & dosage, immunology, Bone Marrow, parasitology, Cell Proliferation, Cricetinae, Cysteine Endopeptidases, administration & dosage, immunology, Cytokines, genetics, Dogs, Enzyme-Linked Immunosorbent Assay, Gene Expression, Immunoglobulin G, blood, Iran, Leishmania infantum, immunology, Leishmaniasis, Visceral, prevention & control, Leukocytes, Mononuclear, immunology, Lymphocytes, immunology, Oligodeoxyribonucleotides, administration & dosage, immunology, RNA, Messenger, analysis, Vaccines, DNA, administration & dosage, immunology, Vaccines, Subunit, administration & dosage, immunology
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Immunology and Infection
Research Centre: Leishmaniasis Group
Vaccine Centre
PubMed ID: 15882533
Web of Science ID: 229484000013
URI: http://researchonline.lshtm.ac.uk/id/eprint/6148

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
300Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item